documents: FDA-2021-N-1326-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-1326-0004 | FDA | FDA-2021-N-1326 | CVM Response to Phibro Animal Health Corporation’s September 18, 2020 Comments on CVM’s July 20, 2020 Proposed Order to Revoke the Regulatory Method for Carbadox | Other | Additional Information | 2022-02-18T05:00:00Z | 2022 | 2 | 2022-02-18T05:00:00Z | 2022-06-19T01:51:03Z | 0 | 0 | 0900006484f82f6a |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref